Kevin Lee
Chief Executive Officer at Bicycle Therapeutics plc
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Bicycle Therapeutics plc, 3 years.
Bicycle Therapeutics plc
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
Bicycle Therapeutics plc
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 3, 2024 | Bicycle Therapeutics plc | Open-market sale | −3,194 | $19.64 | $62,730 |
| Apr 3, 2024 | Bicycle Therapeutics plc | Open-market sale | −3,158 | $23.81 | $75,192 |
| Jan 3, 2024 | Bicycle Therapeutics plc | Open-market sale | −8,703 | $17.50 | $152,303 |
| Jan 2, 2024 | Bicycle Therapeutics plc | Grant or award | +77,000 | — | — |
| Oct 3, 2023 | Bicycle Therapeutics plc | Open-market sale | −1,470 | $20.00 | $29,400 |
| Jul 3, 2023 | Bicycle Therapeutics plc | Open-market sale | −1,498 | $25.10 | $37,600 |
| Apr 3, 2023 | Bicycle Therapeutics plc | Open-market sale | −1,486 | $21.11 | $31,369 |
| Jan 3, 2023 | Bicycle Therapeutics plc | Grant or award | +57,500 | — | — |
| Jan 3, 2023 | Bicycle Therapeutics plc | Open-market sale | −6,000 | $29.06 | $174,360 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.